New Computer Assisted Diagnostic Tests for Ovarian Cancer, Cervical Cancer and Endometrial Cancer to Be Jointly Developed by Health Discovery Corporation (DWCM.OB) and DCL Medical Laboratories
7/24/2008 10:43:42 AM
SAVANNAH, Ga.--(BUSINESS WIRE)--Health Discovery Corporation (OTCBB: HDVY), a leader in support vector machine (SVM) based molecular diagnostics, and DCL Medical Laboratories, LLC, Indianapolis, IN, a full-service, clinical reference laboratory, today announced the signing of a Development and License Agreement for the collaborative development and commercialization of SVM-based computer assisted diagnostic (CAD) tests for the independent detection of ovarian, cervical and endometrial cancers. These new diagnostic tests will be performed on digital images to assist pathologists in providing more accurate diagnoses on biopsy and surgical specimens. HDC shall own the developed intellectual property and DCL shall have a sole use license relating to applications and new mathematical tools developed during the course of this Agreement. The companies will share future service revenues contemplated under the Agreement.
comments powered by